rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2004-5-26
|
pubmed:abstractText |
The matrix metalloproteinase 3 (MMP3), also known as stromelysin-I, is a key-player for carcinogenesis and tumor growth. A 5A/6A promoter polymorphism is associated with differences in MMP3 activity and has been linked to cancer susceptibility in some studies. In the present study we evaluated the role of this polymorphism for breast cancer risk.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1078-0432
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3518-20
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15161710-Adult,
pubmed-meshheading:15161710-Aged,
pubmed-meshheading:15161710-Aged, 80 and over,
pubmed-meshheading:15161710-Alleles,
pubmed-meshheading:15161710-Breast Neoplasms,
pubmed-meshheading:15161710-Case-Control Studies,
pubmed-meshheading:15161710-Female,
pubmed-meshheading:15161710-Genetic Predisposition to Disease,
pubmed-meshheading:15161710-Genotype,
pubmed-meshheading:15161710-Humans,
pubmed-meshheading:15161710-Lymphatic Metastasis,
pubmed-meshheading:15161710-Matrix Metalloproteinase 3,
pubmed-meshheading:15161710-Middle Aged,
pubmed-meshheading:15161710-Models, Genetic,
pubmed-meshheading:15161710-Odds Ratio,
pubmed-meshheading:15161710-Polymorphism, Genetic,
pubmed-meshheading:15161710-Promoter Regions, Genetic
|
pubmed:year |
2004
|
pubmed:articleTitle |
The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
|
pubmed:affiliation |
Department of Internal Medicine, Division of Oncology, Medical University Graz, Graz, Austria. peter.krippl@klinikum-graz.at
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|